p75 neurotrophin receptor regulates NGF-induced myofibroblast differentiation and collagen synthesis through MRTF-A
p75 neurotrophin receptor regulates NGF-induced myofibroblast differentiation and collagen synthesis through MRTF-A
复制标题
p75神经营养素受体通过MRTF-A调节NGF诱导的肌成纤维细胞分化和胶原合成
DOI:
10.1016/j.yexcr.2019.111504
复制
发表时间:
2019-10-01
影响因子:
3.7
通讯作者:
Wang, Yibing
中科院分区:
文献类型:
--
作者:
Liu, Zhenxing;Cao, Yongqian;Wang, Yibing
Myofibroblasts are characterized by de novo expression of a-smooth muscle actin (alpha-SMA) and play a key role in tissue repair and remodeling. In addition to TGF-beta 1, recent studies have shown that nerve growth factor (NGF) has effects on myofibroblast differentiation and collagen synthesis. However, the regulatory mechanism remains poorly defined. NGF effects are mediated by the specific expression of the NGF neurotrophic tropomyosin-receptor kinase A (TrkA) and p75 neurotrophin receptor (p75(NTR)). Using NIH/3T3 fibroblast cell lines, we examined the induction of myofibroblast differentiation stimulated by NGF. Our findings showed that p75(NTR) was in keeping with the expression of alpha-SMA. Herein, we investigated the role of p75(NTR) in NGF-induced myofibroblast differentiation and collagen synthesis in these cells using lentivirus transfection to overexpress and knock down. Our results showed that p75 NTR was preferentially expressed and was sufficient to induce actin cytoskeleton remodeling, which was required for NGF-induced alpha-SMA expression. Furthermore, NGF induced nuclear translocation of MRTF-A, an effect that was regulated by p75(NTR), and required for alpha-SMA and collagen-I expression in myofibroblasts. Using a novel MRTF-A pathway inhibitor, CCG-203971, we further demonstrated the requirement of MRTF-A nuclear localization and activity in NGF-induced alpha-SMA expression. In conclusion, we conclude that p75(NTR) regulates NGF-induced myofibroblast differentiation and collagen synthesis through MRTF-A. Regulation of NGF-p75(NTR) interactions represents a promising therapy for fibrotic disorders.